Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV February 22, 2023 thumbnail

Introduction

story 1 thumbnail

FDA Approves Apellis Pharmaceuticals' Syfovre as First Treatment for Geographic Atrophy

story 2 thumbnail

Iveric Bio’s NDA for GA Drug Candidate Zimura Approved by FDA

story 3 thumbnail

Orasis Pharmaceuticals’ NDA for Investigational Presbyopia Drop Approved by FDA


Previous EyewireTV Episodes